Clinical Trials Directory

Trials / Completed

CompletedNCT02582177

Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis

Phase 3 Study, Randomized, Double-blind, Parallel to Evaluate Ketoconazole and Betamethasone Dipropionate(Candicort®) Compared to Clotrimazole and Dexamethasone Acetate(Baycuten N®) in Relief of Fungal Infections/Dermatophytosis Symptoms.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
125 (actual)
Sponsor
Ache Laboratorios Farmaceuticos S.A. · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

To evaluate the no-inferiority of the ketoconazole20mg/g and betamethasone dipropionate 0.64 mg/g association (Candicort®) cream versus clotrimazole 10mg and dexamethasone acetate 0.443 mg/g association (Baycuten N®) cream, general relief of signs and symptoms (erythema, maceration, peeling, blistering / papules / pustules, itching and burning / stinging) 06 (± 1) days after onset treatment.

Detailed description

Candicort® presents formulation with agents that act both etiological agent of superficial mycosis, with coverage for dermatophytes and more frequent yeast; as inflammation generated by the infectious process or prior to it, in cases of secondary fungal infection in wet or potentially infected eczema fungal dermatitis (atopic dermatitis, seborrhoeic dermatitis, intertrigo, dyshidrosis, contact dermatitis). The active ingredients ketoconazole and betamethasone act, respectively, on the etiologic agent of the infection and the inflammation generated by the process, and the association of both showed a positive therapeutic response in dermatitis with confirmed secondary infections or potential yeast (analysis carried out in association with sulfate neomycin, aimed to cover bacterial infections together). 160 participants that meet all the inclusion criteria and are not classified in any of the exclusion criteria will be randomly allocated to one of two treatment groups(Candicort® or Baycuten N®) of the study.

Conditions

Interventions

TypeNameDescription
DRUGCandicort®Apply on the affected area and around it twice a day
DRUGNizoral®Apply on the affected area and around it twice a day
DRUGBaycuten N®Apply on the affected area and around it twice a day
DRUGCanesten®Apply on the affected area and around it twice a day

Timeline

Start date
2019-06-11
Primary completion
2020-01-20
Completion
2020-03-24
First posted
2015-10-21
Last updated
2021-09-20

Locations

9 sites across 1 country: Brazil

Source: ClinicalTrials.gov record NCT02582177. Inclusion in this directory is not an endorsement.